This week, there are 6 drugs in the patent and exclusivity list. They are: - NOVO NORDISK INC's OZEMPIC, containing active ingredient SEMAGLUTIDE - NOVO NORDISK INC's VICTOZA, containing active ingredient LIRAGLUTIDE - NOVO NORDISK INC's SAXENDA, containing active ingredient LIRAGLUTIDE - NIPPON SHINYAKU CO LTD's VILTEPSO, containing active ingredient VILTOLARSEN - VERTEX PHARMACEUTICALS INC's KALYDECO, containing active ingredient IVACAFTOR - EISAI INC's LENVIMA, containing active ingredient LENVATINIB MESYLATE Read More

This week, there are 16 drugs in the patent and exclusivity list. They are: - UNITED THERAPEUTICS CORP's REMODULIN, containing active ingredient TREPROSTINIL - VALINOR PHARMA LLC's MOVANTIK, containing active ingredient NALOXEGOL OXALATE - OTSUKA PHARMACEUTICAL CO LTD's ABILIFY, containing active ingredient ARIPIPRAZOLE - INTRA-CELLULAR THERAPIES INC's CAPLYTA, containing active ingredient LUMATEPERONE TOSYLATE - PFIZER INC's TOVIAZ, containing active ingredient FESOTERODINE FUMARATE - CUBIST PHARMACEUTICALS LLC's ZERBAXA, containing active ingredient CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM - EISAI INC's LENVIMA, containing active ingredient LENVATINIB MESYLATE - PF PRISM CV's BOSULIF, containing active ingredient BOSUTINIB MONOHYDRATE - AMGEN INC's OTEZLA, containing active ingredient APREMILAST Read More